Novartis, Roche fined €444m in France over eye drug abusive practices

This article was originally published here

The fine has been imposed on the companies for pushing the sales of Lucentis to treat age-related macular degeneration (AMD) over Avastin, which is available at low cost

The post Novartis, Roche fined €444m in France over eye drug abusive practices appeared first on Pharmaceutical Business review.